William P. Burke's Insider Trades & SAST Disclosures
William P. Burke's most recent trade in Axogen Inc. was a trade of 11,904 Common Stock done . Disclosure was reported to the exchange on Sept. 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William P. Burke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc. | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 28,557 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | William P. Burke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 16,653 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | William P. Burke | Director | Purchase of securities on an exchange or from another person at price $ 6.56 per share. | 23 Aug 2023 | 10,000 | 10,000 (0%) | 0% | 6.6 | 65,600 | Common Stock |
| Axogen Inc. | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 6.31 per share. | 23 Aug 2023 | 6,000 | 6,000 (0%) | 0% | 6.3 | 37,860 | Common Stock |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 357 | 66,447 (0%) | 0% | 35.3 | 12,595 | Ordinary Shares |
| Miromatrix Medical Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,201 | 134,356 | - | 0 | Common Stock | |
| Miromatrix Medical Inc | William P. Burke | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 80,155 | - | 1.6 | 50,000 | Common Stock |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.16 per share. | 03 Mar 2023 | 593 | 66,090 (0%) | 0% | 76.2 | 45,163 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 02 Mar 2023 | 281 | 66,683 (0%) | 0% | 75.3 | 21,153 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,168 | 20,168 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,125 | 67,719 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.36 per share. | 28 Feb 2023 | 755 | 66,964 (0%) | 0% | 76.4 | 57,654 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 62.31 per share. | 06 Jan 2023 | 108 | 55,594 (0%) | 0% | 62.3 | 6,729 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 79.04 per share. | 02 Sep 2022 | 718 | 55,486 (0%) | 0% | 79.0 | 56,749 | Ordinary Shares |
| Miromatrix Medical Inc | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 12,788 | 48,905 | - | 0 | Common Stock | |
| Axogen Inc. | William P. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2022 | 59,395 | 0 | - | - | Stock Option (right to purchase) | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 59.08 per share. | 05 Jul 2022 | 213 | 56,204 (0%) | 0% | 59.1 | 12,583 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 08 Mar 2022 | 1,037 | 55,991 (0%) | 0% | 70.1 | 72,694 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,038 | 13,038 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 7,445 | 58,395 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 4,361 | 4,361 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 1,026 | 57,028 (0%) | 0% | 70.4 | 72,238 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 341 | 58,054 (0%) | 0% | 74.5 | 25,404 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 63.81 per share. | 06 Jan 2022 | 80 | 50,950 (0%) | 0% | 63.8 | 5,105 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 17,452 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 03 Jan 2022 | 17,452 | 43,669 (0%) | 0% | 11.5 | 200,000 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 03 Jan 2022 | 9,750 | 50,786 (0%) | 0% | 7.2 | 69,713 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 9,750 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.96 per share. | 03 Jan 2022 | 2,633 | 41,036 (0%) | 0% | 76.0 | 200,003 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.60 per share. | 03 Jan 2022 | 1,402 | 51,269 (0%) | 0% | 21.6 | 30,283 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 1,402 | 6,098 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.09 per share. | 03 Jan 2022 | 919 | 49,867 (0%) | 0% | 76.1 | 69,924 | Ordinary Shares |
| NovoCure Ltd | William Patrick Burke | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.03 per share. | 03 Jan 2022 | 399 | 50,870 (0%) | 0% | 76.0 | 30,336 | Ordinary Shares |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.51 per share. | 23 Aug 2021 | 22,667 | 30,291 (0%) | 0% | 60.5 | 1,371,580 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 11,435 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.64 per share. | 23 Aug 2021 | 11,435 | 52,958 (0%) | 0% | 41.6 | 476,153 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.21 per share. | 23 Aug 2021 | 11,232 | 41,523 (0%) | 0% | 34.2 | 384,247 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 11,232 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 66.60 per share. | 01 Jul 2021 | 4,293 | 30,291 (0%) | 0% | 66.6 | 285,914 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.87 per share. | 14 Jun 2021 | 190 | 34,584 (0%) | 0% | 59.9 | 11,375 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.09 per share. | 07 Jun 2021 | 411 | 34,774 (0%) | 0% | 55.1 | 22,642 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 17,933 | 17,933 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 17,677 | 35,423 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,628 | 17,746 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 18 May 2021 | 238 | 35,185 (0%) | 0% | 55.2 | 13,135 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.97 per share. | 17 May 2021 | 219 | 11,118 (0%) | 0% | 56.0 | 12,257 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 26 Oct 2020 | 1,161 | 11,337 (0%) | 0% | 106 | 123,066 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 22,334 | 35,029 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.71 per share. | 12 Jun 2020 | 9,720 | 25,112 (0%) | 0% | 87.7 | 852,541 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.38 per share. | 12 Jun 2020 | 6,146 | 13,707 (0%) | 0% | 91.4 | 561,621 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.36 per share. | 12 Jun 2020 | 5,259 | 19,853 (0%) | 0% | 90.4 | 475,203 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 92.09 per share. | 12 Jun 2020 | 1,209 | 12,498 (0%) | 0% | 92.1 | 111,337 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.29 per share. | 12 Jun 2020 | 197 | 34,832 (0%) | 0% | 89.3 | 17,590 | Common Stock |
| Haemonetics Corp. | William P. Burke | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.03 per share. | 08 Jun 2020 | 639 | 12,695 (0%) | 0% | 97.0 | 62,002 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges